[go: up one dir, main page]

KR950031085A - 표피증식 질환 치료용 의약 조성물 - Google Patents

표피증식 질환 치료용 의약 조성물 Download PDF

Info

Publication number
KR950031085A
KR950031085A KR1019950008911A KR19950008911A KR950031085A KR 950031085 A KR950031085 A KR 950031085A KR 1019950008911 A KR1019950008911 A KR 1019950008911A KR 19950008911 A KR19950008911 A KR 19950008911A KR 950031085 A KR950031085 A KR 950031085A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
acceptable salt
pharmacologically acceptable
treatment
compound
Prior art date
Application number
KR1019950008911A
Other languages
English (en)
Inventor
가즈미 오가다
다까히로 사까우에
사찌꼬 마쓰우라
리에 나가오
신야 오기노
Original Assignee
요시다 쇼오지
센쥬 세이야꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼오지, 센쥬 세이야꾸 가부시기가이샤 filed Critical 요시다 쇼오지
Publication of KR950031085A publication Critical patent/KR950031085A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

아래의 구조식의 안산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 표피 증식 치료용 의약 조성물.
위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.
본 발명의 조성물은 건선(乾癬), 어린선(魚鱗蘚), 손바닥 또는 발바닥 각피증 및 모공성 홍색 비강진(pityriasis rubra pillaris)등의 표피 증식 질환의 치료제로 유용하다.

Description

표피증식 질환 치료용 의약 조성물.
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
보통의 건선이 있는 마우스 모델에서의 시간 경과에 따른 귀의 팽윤율을 나타내는 그래프.

Claims (6)

  1. 아래의 구조식의 인산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 표피 증식 치료용 의약 조성물.
    위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.
  2. 제1항에 있어서, 국소 적용용의 의약 조성물.
  3. 제2항에 있어서, 연고제, 액제 또는 겔제인 국소 적용용의 의약 조성물.
  4. 제3항에 있어서, 상기 화합물 또는 약리학적으로 허용되는 염의 상기 연고제 또는 겔제중에서의 농도가 0.01∼5(w/w)%인 의약 조성물.
  5. 제3항에 있어서, 상기 화합물 또는 약리학적으로 허용되는 염의 상기 액제중에서의농도가 0.01∼5(w/w)%인 의약 조성물.
  6. 아래의 구조식의 인산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 의약 조성물의 유효량을 표피 증식 질환을 가진 환자에게 투여하는 표피 증식 질환 치료방법.
    위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950008911A 1994-04-22 1995-04-15 표피증식 질환 치료용 의약 조성물 KR950031085A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP94-84248 1994-04-22
JP8424894 1994-04-22

Publications (1)

Publication Number Publication Date
KR950031085A true KR950031085A (ko) 1995-12-18

Family

ID=13825166

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950008911A KR950031085A (ko) 1994-04-22 1995-04-15 표피증식 질환 치료용 의약 조성물

Country Status (6)

Country Link
EP (1) EP0679399B1 (ko)
KR (1) KR950031085A (ko)
AT (1) ATE156359T1 (ko)
DE (1) DE69500511T2 (ko)
ES (1) ES2107279T3 (ko)
TW (1) TW287103B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2209690A1 (en) * 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
WO2002026238A1 (en) * 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2003011303A1 (en) * 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
DK1720551T3 (da) 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US20090005348A1 (en) * 2005-12-23 2009-01-01 Vital Health Sciences Pty Ltd Compounds Having Cytokine Modulating Properties
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
NZ602572A (en) 2010-03-30 2014-11-28 Phosphagenics Ltd Transdermal delivery patch
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
WO2017096427A1 (en) 2015-12-09 2017-06-15 Phosphagenics Limited Pharmaceutical formulation
EP3558903B1 (en) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Process for phosphorylating a complex alcohol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
US5122536A (en) * 1989-10-12 1992-06-16 Perricone Nicholas V Method for the topical treatment of psoriasis

Also Published As

Publication number Publication date
DE69500511T2 (de) 1998-01-02
EP0679399A1 (en) 1995-11-02
TW287103B (ko) 1996-10-01
DE69500511D1 (de) 1997-09-11
ES2107279T3 (es) 1997-11-16
ATE156359T1 (de) 1997-08-15
EP0679399B1 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
KR950031085A (ko) 표피증식 질환 치료용 의약 조성물
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
DE69815122D1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR0110420A (pt) Agonistas muscarìnicos
DE69019111D1 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
NO981528D0 (no) Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet
DE69903750D1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
ATE177640T1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
RU94044489A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
KR950016760A (ko) 치질 치료제
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19950415

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20000313

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19950415

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20020731

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20021226

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20020731

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I